BDRX
Biodexa PharmaceticalsNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.54M
P/E Ratio
—
EPS
$-3.31
Beta
1.11
52W High
$96.50
52W Low
$3.00
50-Day MA
$5.36
200-Day MA
$23.48
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biodexa Pharmaceticals
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in the United Kingdom, rest of Europe, and internationally. The company is headquartered in Cardiff, the United Kingdom.
Fundamentals
| Revenue (TTM) | 83,000 |
| Gross Profit (TTM) | $-3.96M |
| EBITDA | $-8.59M |
| Operating Margin | 0.00% |
| Return on Equity | -64.70% |
| Return on Assets | -32.80% |
| Revenue/Share (TTM) | $0.43 |
| Book Value | $24.49 |
| Price-to-Book | 0.95 |
| Price-to-Sales (TTM) | 10.16 |
| EV/Revenue | 25.89 |
| EV/EBITDA | 0.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -64.10% |
| Shares Outstanding | $3.24M |
| Float | $26.42B |
| % Insiders | 0.07% |
| % Institutions | 9.95% |
Data last updated: 4/7/2026